7181 - 7190 of 7915 Results
Title
Year
- Permeabilization of the Blood-Brain Barrier via Mucosal Engrafting: Implications for Drug Delivery to the Brain2013OPENTitle: Permeabilization of the Blood-Brain Barrier via Mucosal Engrafting: Implications for Drug Delivery to the BrainJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 4Start Page: e61694End Page: e61694Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0061694Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0061694&type=printableCitation Count: 36
- Correlation of Inner Retinal Thickness Evaluated by Spectral-Domain Optical Coherence Tomography and Contrast Sensitivity in Parkinson disease2013OPENTitle: Correlation of Inner Retinal Thickness Evaluated by Spectral-Domain Optical Coherence Tomography and Contrast Sensitivity in Parkinson diseaseJournal Name: Journal of Neuro-OphthalmologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 33Issue #: 2Start Page: 137End Page: 142Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wno.0b013e31828c4e1aBest OA location URL: https://journals.lww.com/jneuro-ophthalmology/fulltext/2013/06000/correlation_of_inner_retinal_thickness_evaluated.9.aspxCitation Count: 77
- Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetin2013RESTRICTEDTitle: Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetinJournal Name: Biochemical PharmacologyPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 1816End Page: 1826Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bcp.2013.04.010Citation Count: 75
- TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies2013OPENTitle: TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 126Issue #: 1Start Page: 51End Page: 57Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-013-1110-0Best OA location URL: https://europepmc.org/articles/pmc3691299?pdf=renderCitation Count: 85
- Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse Model2013OPENTitle: Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse ModelJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 4Start Page: e61700End Page: e61700Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0061700Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0061700&type=printableCitation Count: 112
- α4β2 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian rats2013OPENTitle: α4β2 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 71Issue #:Start Page: 191End Page: 203Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.03.038Best OA location URL: https://europepmc.org/articles/pmc3685407?pdf=renderCitation Count: 42
-
RESTRICTEDTitle: α‐Synuclein: The Long Distance RunnerJournal Name: Brain PathologyPublisher: WileyVol: 23Issue #: 3Start Page: 350End Page: 357Publication Date:Open Access(OA) Status: RESTRICTEDLicense: unspecified-oaDOI - Digital Object Identifier: 10.1111/bpa.12046Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bpa.12046Citation Count: 102
-
RESTRICTEDTitle: Lysosomal impairment in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 6Start Page: 725End Page: 732Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25462Best OA location URL: https://europepmc.org/articles/pmc5131721?pdf=renderCitation Count: 267
-
OPENTitle: Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patientsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 18Start Page: 1698End Page: 1701Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182904faaBest OA location URL: https://europepmc.org/articles/pmc3716474?pdf=renderCitation Count: 185
- Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies2013OPENTitle: Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodiesJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 453Issue #: 1Start Page: 101End Page: 113Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bj20121742Best OA location URL: https://portlandpress.com/biochemj/article-pdf/453/1/101/675176/bj4530101.pdfCitation Count: 90